Ask the expert: Source patient testing after a needlestick is the law for employers, not an option
Q: Just where does it say that we must test the source patient’s blood after an employee has a needlestick injury? My medical director is questioning the need for this.
A: In all occupational needlestick injuries, the employer is required to obtain a blood sample for testing from the source patient, pending consent applicable to state laws. If consent is not obtained then you must document your efforts as part of the post-exposure follow up record.
Also, it is important that you obtain the blood work as soon as possible from the source patient, preferably immediately, as quick results give the referring healthcare professional and exposed worker the most options should post-exposure prophylaxis be needed.
These requirements are federal regulations (or state regulations in states that administer occupational safety and health programs).
The section of Bloodborne Pathogens Standard applicable to your question is 29 CFR 1910.1030 (f)(3) (A):
“The source individual’s blood shall be tested as soon as feasible and after consent is obtained in order to determine HBV and HIV infectivity. If consent is not obtained, the employer shall establish that legally required consent cannot be obtained.”
OSHA’s Enforcement Procedures for the Occupational Exposure to Bloodborne Pathogens, the document that OSHA officials use to conduct inspections, adds:
The employer must ask for consent from the source individual or anyone legally authorized to give consent on his/her behalf.
See the free Bloodborne Pathogens Postexposure Checklist on the Tool page. It lists all the steps for compliance after a needlestick, including source patient testing.
« When you just can’t get enough of occupational exposure to liver diseases | Home | Good, clean advice from Mac’s Safety Space »





Comments
What happens if the patient refuses the blood draw? We have some cases of that in a psyche facility; we normally wait until they agree, I see the urgency of it – can we force them? It is their right and is hard to explain some times with psyche patients.
Yes, I can imagine your situation. The enforcement reference cited above goes on to say:
If legally-required consent is not obtained, the employer must establish this. This fact should be documented in writing, unless there is other clear evidence that consent could not be obtained. The compliance officer should ensure that the employer’s plan includes this provision.
For those jurisdictions that do not require consent of the individual, available blood may be used for testing rather than redrawing a specimen. The term “if available” applies to blood samples that have already been drawn from the source individual. OSHA does not require redrawing of blood specifically for HBV and HIV testing without the consent of the source individual.
The tricky thing is that while the federal OSHA requirement to attempt to obtain consent for source patient blood sampling covers multiple states, the state themselves have their unique consent rules.
In your situation it would be very important to be absolutely clear what your state consent rules are, when you can use available blood for testing rather than drawing a specimen, and in what cases you can resort to “anyone legally authorized to give consent on his/her behalf.”
I suggest the legal counsel for your facility as the first place to start.
What about fine particle nebulizer exposure with pt with known MRSA and Hep C? How is this handled with OSHA is it a blood borne pahtogen exposure?
OSHA definition of an exposure under the bloodborne pathogens is:
“Exposure Incident means a specific eye, mouth, other mucous membrane, non-intact skin, or parenteral contact with blood or other potentially infectious materials that results from the performance of an employee’s duties.”
You might want to consult an infectious disease expert to determine the likelihood of infectious substances from a nebulizer.
My company is looking into the possibility of using ficticious names for source patients due to confidentiality. My opinion is that all lab results are considered confidential. I am concerned about not using the real names. Is there anything In the QHSA regs that addresses the use of ficticious names?
There is nothing in the federal OSHA bloodborne pathogens standard that addresses the use of fictitious names, but there is clear cut language requiring the employer to inform the exposed employee of the “identification of the source individual,” according to section 1910.1030(f)(3)(ii) of the standard.
One of the basic precepts of OSH Act of 1970, which granted the authority to create OSHA, is that employees have a right to know about and to receive protection from hazards in the workplace. The use of fictitious names for source patients places a barrier to that right to know and puts you on track for a serious, and possibly willful, violation, in my opinion.
Employers have the responsibility, however, under section (f)(3)(ii)(C) of the standard to advise the employee to maintain confidentiality according to applicable laws and regulations concerning disclosure of the identity and infectious status of the source individual.
If it is HIPAA that you worried about violating, see the post “Ask the Expert—OSHA vs. HIPAA.” It gives the HIPAA citation for disclosing information that is required by law, which includes OSHA standards.
Q: With needlestick accidents, my company is looking into the possibility of using fictitious names for source patients on lab reports due to confidentiality. Is there anything In the OSHA regulations that addresses the use of fictitious names?
A: There is nothing in the federal OSHA bloodborne pathogens standard that addresses the use of fictitious names, but there is clear cut language requiring the employer to inform the potentially exposed employee of the “identification of the source individual,” <a href=”http://www.osha.gov/pls/oshaweb/owadisp.show_document?p_table=STANDARDS&p_id=10051″ rel=”nofollow”>according to section 1910.1030(f)(3)(ii) of the standard.</a>
One of the basic precepts of OSH Act of 1970, which granted the authority to create OSHA, is that employees have a right to know about and to receive protection from hazards in the workplace. The use of fictitious names for source patients places a barrier to that right to know and puts you on track for a serious, and possibly willful, violation, in my opinion.
If it is HIPAA that you worried about violating, see the post <a href=”http://blogs.hcpro.com/osha/2009/01/ask-the-expert%E2%80%94bloodborne-pathogens-osha-vs-hipaa/” rel=”nofollow”>”Ask the Expert—OSHA vs. HIPAA.”</a> It gives the HIPAA citation for disclosing information that is required by law, which includes OSHA standards.
Hypothetically, a party presnets to a facility and has a blood standard drawn. The employee who drew the standard now suffers a needlestick. Employer attempts to contact the party for consent without success. May the employer test the standard to protect the employee?
I am trying to ensure that source patients are drawn as quickly as possible after an employee exposure. Are we allowed to have patients sign consent upon admission that in the event of an exposure they agree for testing?
Leave a Comment